Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05467891
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-01-05
First Post:
2022-06-28
Brief Title:
Ribociclib And Endocrine Treatment of Physicians Choice for Locoregional Recurrent Resected Hormone Receptor Positive HER2 Negative Breast Cancer
Sponsor:
Organization:
Hoosier Cancer Research Network